Tumor growth was reduced in mouse models of breast cancer, colon cancer, and melanoma after the protein MerTK was removed from immune cells, researchers reported.
The Society of Thoracic Surgeons (STS) has released new clinical-practice guidelines that feature evidence-based recommendations to help clinicians diagnose and stage esophageal cancer.
New data has confirmed the biological action of the drug MGN1703 and suggests that it may be possible to identify which patients with gastrointestinal cancer will benefit most from the treatment.
Researchers have identified a biomarker for colorectal cancer that can be obtained from a small amount of serum DNA in less than 1 mL of blood and that is highly sensitive and specific for the disease.
IN a recent study, colorectal tumors that had developed resistance to anti-epidermal growth factor receptor (anti-EGFR) therapies responded to drugs that block the action of the MET oncogene.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|